Talus Bio

Developer of a data-enabled drug development platform designed to offer small-molecule therapy in oncology. The company's platform combines cell processing with high-sensitivity quantitative proteomic...

Healthcare

Seattle, WA, United States

Founded 2020

27 employees

Website

Valuation

$31.2M

Market implied

Share Price

N/A

Total Raised

$19.6M

Last Round

Unknown

Latest Funding Round

Unknown

View all funding rounds

Investors

+46 other investors

View all 46 investors

Valuation History

1 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Talus Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required